American Thrombosis and Hemostasis Network
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, American Thrombosis and Hemostasis Network sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
American Thrombosis and Hemostasis Network: 8 sponsored US clinical trials, 3 recruiting.
American Thrombosis and Hemostasis Network sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Von Willebrand Diseases, with 2 trials.
Upper-quartile sponsor footprint
American Thrombosis and Hemostasis Network sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
ATHNdataset Registry
NCT06820515
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
NCT04647227
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
NCT04398628
ATHN 9: Severe VWD Natural History Study
NCT03853486
ATHN 11: Liver Transplantation Outcomes Study
NCT04055051
ATHN 7: Hemophilia Natural History Study
NCT03619863
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
NCT03818529
ATHN 2: Factor Switching Study
NCT02546622
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Where American Thrombosis and Hemostasis Network enrollment is open (later-stage tilt)
3 recruiting of 8 indexed (38% open); 4 completed (50%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Von Willebrand Diseases (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
American Thrombosis and Hemostasis Network: open-pipeline peers nationwide
Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
American Thrombosis and Hemostasis Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 38% open enrollment (± trial volume)
- AskBio · 38% recruiting · 8 trials
- Athletic Greens International · 38% recruiting · 8 trials
- Banner Health · 38% recruiting · 8 trials
- CND Life Sciences · 38% recruiting · 8 trials
Related
What to do with this American Thrombosis and Hemostasis Network page
8 registered trials is a research-attention snapshot, not an endorsement of American Thrombosis and Hemostasis Network or any single study.
- 3 of American Thrombosis and Hemostasis Network's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Von Willebrand Diseases is the condition American Thrombosis and Hemostasis Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Von Willebrand Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
American Thrombosis and Hemostasis Network pipeline card: 8 registered trials from official public datasets.Report a data error.